Shimadzu : NOTICE OF RESOLUTIONS AT THE 162ND ANNUAL GENERAL MEETING OF SHAREHOLDERS

Published June 26, 2025 at 5:14 a.m. UTC

Source: MarketScreener

Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.

June 26, 2025

To Our Shareholders

Yasunori Yamamoto

Representative Director, President & CEO SHIMADZU CORPORATION

1, Nishinokyo Kuwabara-cho, Nakagyo-ku, Kyoto, Japan

NOTICE OF RESOLUTIONS AT THE 162ND ANNUAL GENERAL MEETING OF SHAREHOLDERS

Dear Shareholders:

The following matters were reported and resolved at the 162nd Annual General Meeting of Shareholders of SHIMADZU CORPORATION (the Company), held today.

Matters Reported : 1. The Business Report, Consolidated Financial Statements for the 162nd Fiscal Year (April 1, 2024 - March 31, 2025) and results of audits of the Consolidated Financial Statements by the Accounting Auditor and the Audit & Supervisory Board

2. Non-consolidatedFinancial Statements for the 162nd Fiscal Year (April 1, 2024 -March 31, 2025)

The contents of the above documents were reported.

Matters Resolved : Proposal 1: Appropriation of Surplus

Resolved as originally proposed by the Company, with the payment of year-end dividend of 40yen per share.

Proposal 2: Election of Seven (7) Directors, Members of the Board

Mr. Teruhisa Ueda, Mr. Yasunori Yamamoto, Mr. Akira Watanabe, Mr. Nobuo Hanai, Mr. Yoshiyuki Nakanishi, Ms. Nami Hamada and Ms. Mie Kitano were re-appointed, and all assumed their offices, as originally proposed by the Company.

Note: Mr. Nobuo Hanai, Mr. Yoshiyuki Nakanishi, Ms. Nami Hamada and Ms. Mie Kitano are Outside Directors.

Proposal 3: Election of One (1) Audit & Supervisory Board Member

Mr. Yoichi Yamada was newly appointed as an Audit & Supervisory Board Member, and he assumed his offices, as originally proposed by the Company.

Payment of Year-End Dividends

Please obtain your year-end dividend for the 162nd Fiscal Year from any nearby office of Japan Post Bank Co., Ltd., or post office within the payment period (from Friday, June 27, 2025 to Thursday, July 31, 2025) by presenting "Dividend Receipt." For shareholders who have already designated a bank account or any other account to which dividends are to be remitted, please refer to "Dividend Statement" and "Reference to the Transfer Destination."

Executive Members

As a result of the resolutions passed at the meeting of the Board of Directors which was held after the conclusion of the Annual General Meeting of Shareholders, the Representative Directors have been appointed, and they have assumed their respective offices.

Therefore, the following is a list of the Company's Executive members as of June 26, 2025 (See, (1) below).

The list of the Executive Officers and Corporate Officers as of April 1, 2025 is as follows (See, (2) and

(3) below).

We would like to express our appreciation for your continued support.

Directors, Members of the Board and Audit & Supervisory Board Members
Representative Director Teruhisa Ueda Representative Director Yasunori Yamamoto Director, Member of the Board Akira Watanabe
Outside Director, Member of
the Board
Outside Director, Member of the Board
Outside Director, Member of the Board
Outside Director, Member of the Board
Audit & Supervisory Board Member
Audit & Supervisory Board Member
Outside Audit & Supervisory Board Member
Outside Audit & Supervisory Board Member
Nobuo Hanai Yoshiyuki Nakanishi Nami Hamada
Mie Kitano Makoto Koyazaki
Yoichi Yamada (newly appointed) Tsuyoshi Nishimoto
Yuka Hayashi
Executive Officers

Name	Current Position	Responsibility at the Company
Teruhisa Ueda *	Chairman of the Board
	[Reasons for appointment] As Chairman of the Board, Mr. Teruhisa Ueda is running the Board appropriately and he is committed to enhancing corporate value by strengthening corporate governance. Based on his high insight, abundant experience, and distinguished track record in corporate management and the Company's businesses, the Company expects him to fulfill his role in strengthening the Board's functions for decision-making on important matters and for monitoring and oversight of business execution. Therefore, the Company continues to appoint him again as a Chairman of the Board.
Yasunori Yamamoto *	President & CEO
	[Reasons for appointment] As the CEO, Mr. Yasunari Yamamoto is responsible for management of the Group, and he is committed to enhancing corporate value and promoting the medium-term management plan. Based on his abundant experience and a distinguished track record in a business in addition to having served as corporate manager with the strong leadership, the Company expects him to fulfill his role in promoting the medium-term management plan and enhancing corporate value. Therefore, the Company continues to appoint him again as a President & CEO.
Akira Watanabe *	Senior Managing Executive Officer	In charge of Risk Management In charge of Global Environmental Management(GX) In charge of Corporate Transformation(CX)
	[Reasons for appointment] Responsible for Risk Management, Global Environmental Management, and Corporate Transformation, Mr. Akira Watanabe is fulfilling accountability to the Board and contributing to improving the Board's functions for decision-making on important matters and for oversight of business execution. Based on his abundant knowledge and track record as General Manager of the Industrial Machinery business and Fluidics Systems business, in sales operations, marketing, and management of an overseas subsidiary, in addition to having served as CFO and being responsible for company-wide departments such as Corporate Strategy Planning and Corporate Communications, the Company expects him to fulfill his role in contributing to the Group's sustainable growth and enhancing corporate value. Therefore, the Company continues to appoint him again as a Senior Managing Executive Officer.
Katsuaki Kaito	Senior Managing Executive Officer	In charge of Manufacturing and CS Management In charge of DX·IT Strategy In charge of Medical Regulations
	[Reasons for appointment] Responsible for Manufacturing, CS Management, DX·IT Strategy and Medical Regulations, Mr. Katsuaki Kaito is committed to the quality improvement, cost reduction, shortening of the lead time for delivery, promoting DX·IT Strategy and compliance with regulations in the Med-Tech field. Based on his abundant knowledge and track record in technology & manufacturing fields, cultivation of human resources and management of an overseas subsidiary, the Company expects him to fulfill his role in optimizing the manufacturing functions to improve the quality and reduce costs, promoting DX · IT Strategy and compliance with regulations in the Med-Tech field. Therefore, the Company has appointed him again as a Senior Managing Executive Officer.

Name	Current Position	Responsibility at the Company
Koki Aoyama (promoted)	Senior Managing Executive Officer	Managing Director, Shimadzu (Hong Kong) Ltd. (Currently posted to China)
	[Reasons for appointment] As Managing Director of the Company's business in China, Mr. Koki Aoyama is committed to expanding the business performance with strong leadership. Based on his abundant knowledge and track record in marketing and service fields in addition to Medical Systems business and the management of an overseas subsidiary, the Company expects him to fulfill the leading role in accelerating the integration of analytical instrument technologies with medical systems and realizing new business opportunities in a changing economic environment. Therefore, the Company has newly appointed him as a Senior Managing Executive Officer.
Yoshino Kajitani	Managing Executive Officer	In charge of Legal Affairs and Diversity Management In charge of Health Management
	[Reasons for appointment] Ms. Yoshino Kajitani has abundant knowledge and track record in overseas business and corporate communications as well as the management of a domestic subsidiary, and is in charge of diversity management and health management, aiming to create an organization in which diverse employees can contribute to the business by demonstrating their strengths. In addition, responsible for Legal Affairs, the Company expects her to fulfill her role in strengthening the Group's legal compliance system and business foundation, and has appointed her again as a Managing Executive Officer.
Shigenori Aoyama	Managing Executive Officer	CHRO In charge of General Administration, and Internal Control Deputy in charge of Risk Management
	[Reasons for appointment] Based on his abundant knowledge of the corporate sector, Mr. Shigenori Aoyama is in charge of general affairs and internal control, which are responsible for governance and strengthening of the business foundation. In addition, responsible for Human Resources with abundant experience, the Company expects him to fulfill his role as CHRO in leading human resources management in the Group, including human resources development for directors, officers and employees. Therefore, the Company continues to appoint him again as a Managing Executive Officer.

Name	Current Position	Responsibility at the Company
Shunei Matoba	Managing Executive Officer	In charge of Corporate Marketing General Manager, Sales & Marketing Division General Manager, Tokyo Office
	[Reasons for appointment] Responsible for Corporate Marketing as a General Manager of Tokyo Office and a General Manager, Sales & Marketing Division, Mr. Shunei Matoba is committed to strengthening the corporate marketing organization. Based on his abundant knowledge and track record in the field of sales, marketing and service in addition to Analytical & Measuring Instruments business and management of an overseas subsidiary, the Company expects him to fulfill his role in leading the sales capabilities of the Group. Therefore, the Company has appointed him again as a Managing Executive Officer.
Masami Tomita	Managing Executive Officer	General Manager, Analytical & Measuring Instruments Division
	[Reasons for appointment] As General Manager of Analytical & Measuring Instruments Division, Mr. Masami Tomita is committed to expanding the business and enhancing the functions of the organization. He has abundant knowledge and track record in the technology and product development of liquid chromatographs, one of the Company's main products, and in the technology development and manufacturing of all analytical instruments. Therefore, the Company expects him to fulfill his role in contributing to the growth and improving the profitability of the Analytical & Measuring Instruments business, and has appointed him again as a Managing Executive Officer.
Kiyohito Sonoki	Managing Executive Officer	General Manager, Medical Systems Division
	[Reasons for appointment] As General Manager of Medical Systems Division, Mr. Kiyohito Sonoki is committed to expanding the business and increasing the profitability. Based on his abundant knowledge and track record in the corporate strategy planning and the management of an overseas subsidiary in addition to the technology and product development of medical systems, the Company expects him to fulfill his role in further improving the profitability and expand the overseas business. Therefore, the Company has appointed him again as a Managing Executive Officer.